Study on Necessity and Feasibility of Timely Adjustment Management of Essential Medicine List in China

OBJECTIVE To study the necessity and feasibility of timely adjustments to China's essential medicine list, and propose policy recommendations for improving the dynamic adjustment mechanism.

METHODS Through literature research and descriptive analysis, the necessity was analyzed from 3 dimensions: the basic national conditions, the new situation of drug development, and the changes in the guideline adjustment cycle; feasibility was analyzed based on domestic regulations and international experience.

RESULTS It was necessary for China to establish a timely adjustment mechanism for the essential drug list, which had a legal and regulatory basis and international experience for reference, making it feasible.

CONCLUSION It is recommended to improve the dynamic adjustment mechanism by establishing a model of "three-year regular adjustments plus one-year timely adjustments", formulating supporting policies to enhance the advancement and rationality of the directory, making it more aligned with clinical needs, and better playing the role of ensuring drug supply, promoting rational drug use, and improving drug accessibility.